ALPHA TRIBE

Archean Chemical Industries LimitedInvestor Meet, 18-02-2025: Analysts/Institutional Investor Meet/Con. Call Updates

18-02-2025 | 06:55 pm

**Financial Performance:**

Archean Chemical Industries Limited reported revenue of ₹255 crores for Q3 FY ‘25, showing resilience despite some short-term demand moderation. EBITDA grew to ₹96.3 crores, achieving a margin of 38%. Operational profit rose from ₹69.8 crores in Q2 FY ‘25 to ₹75.5 crores, indicating ongoing operational efficiency. For the nine months of FY ‘25, total income was ₹730.1 crores, down from ₹1,078.9 crores year-on-year, primarily due to market challenges impacting average realizations.

**Future Outlook and Growth Drivers:**

Management remains optimistic about the long-term growth trajectory despite macroeconomic uncertainties, with expectations of demand recovery post-Chinese New Year. The company targets gradual revenue growth from bromine and industrial salt, bolstered by strong customer relationships and enhanced supply chain efficiencies. The semiconductor facility represents a significant strategic investment, projected to further drive growth.

**Order Book and Operational Updates:**

The company’s order book remains healthy, with significant volumes locked in for both bromine and salt. Management noted a recovery in the bromine market and expectations of improved salt dispatches following the resolution of weather-related disruptions.

**Analyst Q&A Insights:**

- *Revenue and Profitability*: Analysts questioned revenue projections, with management indicating a potential uptick in demand and pricing for bromine beginning in Q1 FY ‘26.

- *Market Position and Competitive Landscape*: Responding to concerns about competitive pressures from major suppliers, management reaffirmed their strong market positions and robust demand outlook.

- *Operational Challenges or Risks*: Management expressed confidence in mitigating supply chain and logistical challenges, particularly those affecting salt volumes.

- *Capex and Capital Allocation*: Questions regarding the ₹3,000 crore semiconductor investment revealed plans for careful leverage, supported by central government subsidies.

- *Strategic Priorities and Long-Term Vision*: The company highlighted long-term value creation through sustainability initiatives, including renewable energy sourcing.

**Market or Regulatory Updates:**

Management mentioned their recognition for Responsible Care certification, affirming their commitment to sustainability and ethical practices.

**Strategic Focus Areas:**

Key strategic themes include market share expansion, operational efficiencies, and the entrance into high-growth sectors like semiconductors and energy storage, reflecting a proactive posture amid market challenges.

**Investor Insight:**

The combination of strong operational performance, a solid growth pipeline, and strategic investments suggests a 'buy' position in light of future revenue recovery and growth potential. However, investors should remain cautious of ongoing market pressures and execution risks associated with ambitious capital projects.

No comments yet. Be the first to comment!

All announcements from Archean Chemical Industries Limited